Substantial evidence has suggested that the activity of the bed nucleus of the stria terminalis (BNST) mediates many forms of anxiety-like behavior in human and non-human animals. These data have led many investigators to suggest that abnormal processing within this nucleus may underlie anxiety disorders in humans, and effective anxiety treatments may restore normal BNST functioning. Currently some of the most effective treatments for anxiety disorders are drugs that modulate serotonin (5-HT) systems, and several decades of research have suggested that the activation of 5-HT can modulate anxiety-like behavior. Despite these facts, relatively few studies have examined how activity within the BNST is modulated by 5-HT. Here we review our own investigations using in vitro whole-cell patch-clamp electrophysiological methods on brain sections containing the BNST to determine the response of BNST neurons to exogenous 5-HT application. Our data suggest that the response of BNST neurons to 5-HT is complex, displaying both inhibitory and excitatory components, which are mediated by 5-HT 1A , 5-HT 2A , 5-HT 2C and 5-HT 7 receptors. Moreover, we have shown that the selective activation of the inhibitory response to 5-HT reduces anxietylike behavior, and we describe data suggesting that the activation of the excitatory response to 5-HT may be anxiogenic. We propose that in the normal state, the function of 5-HT is to dampen activity within the BNST (and consequent anxiety-like behavior) during exposure to threatening stimuli; however, we suggest that changes in the balance of the function of BNST 5-HT receptor subtypes could alter the response of BNST neurons to favor excitation and produce a pathological state of increased anxiety.
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Anxiety disorders affect more than 40 million Americans annually (DuPont et al., 1996) , and changes in serotonin (5-HT) functioning have been linked to both their etiology and treatment. Although there is substantial evidence that changes in 5-HT functioning can modulate fear and anxiety-like states in humans and animals alike, the literature is unclear regarding the valence of this modulation, such that treatments that deplete central 5-HT have been shown to produce both anxiolytic or anxiogenic behavioral changes (see (Handley, 1995) for review). This paradox is highlighted by the observation that selective serotonin reuptake inhibitors (SSRIs), which currently are the most-prescribed medication for the treatment of anxiety disorders, produce therapeutic reductions in anxiety only after several weeks of treatment, and yet the acute effects of SSRI treatment often are associated with increases in anxiety-like behavior in both humans and animals alike (Burghardt et al., 2004; Grillon et al., 2007) .
Substantial evidence suggests that the activity of the bed nucleus of the stria terminalis (BNST) mediates many forms of anxiety-like behavior in humans and animals (Straube et al., 2007; Walker et al., 2003; Walker and Davis, 2008) , leading investigators to suggest that abnormal processing within this nucleus may underlie anxiety disorders in humans, and effective anxiety treatments may depend, in part, on restoring normal BNST functioning. As mentioned above, the most effective treatments for anxiety disorders are drugs that modulate 5-HT systems, either by blocking the reuptake of 5-HT or by modulating the activity of specific 5-HT receptor subtypes. As we will show, the BNST receives a reasonably dense innervation by serotonergic afferents (Commons et al., 2003; Phelix et al., 1992) , and multiple 5-HT receptor subtypes are expressed within this region (see below). Despite these important observations, Progress in Neuro-Psychopharmacology & Biological Psychiatry 33 (2009 ) 1309 -1320 
